Alterity Therapeutics
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Open-Label Access to ATH434 for Patients Who Completed Study ATH434-201 in France (NCT07729852) | Alterity Therapeutics | 2026-07-01 |
| A Biomarker Study of ATH434 in Participants With MSA (NCT05864365) | Alterity Therapeutics | 2023-05-23 |
| Study of ATH434 in Participants with Multiple System Atrophy (NCT05109091) | Alterity Therapeutics | 2022-07-01 |
Track Alterity Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.